Jones Walker Logo
  • News & Insights
  • Professionals
  • Services
  • News & Insights
  • Professionals
  • Services

  • Firm
  • Offices
  • Careers
  • Events
  • Media Center
  • Blogs
  • Contact

  • text

Myla R.
Reizen

Position
Partner
Office
Miami

Myla Reizen is a partner in the Corporate Practice Group and a member of the firm’s Healthcare Industry Team, where she focuses her practice on government and internal investigations, healthcare regulatory matters, and compliance.


Myla has extensive experience representing international and national organizations and individual clients from every sector of the complex, competitive, and highly regulated healthcare industry. She also draws on her firsthand in-house experience to provide sophisticated, practical advice to a wide array of healthcare providers.

Among other clients, Myla advises public and private health systems, hospitals, academic medical centers, clinical laboratories, home-health agencies, skilled-nursing and other post-acute-care facilities, hospices, physician groups, behavioral-health providers and facilities, durable medical equipment companies, and more.

In Myla’s comprehensive healthcare practice, she advises providers on enforcement and qui tam matters ranging from traditional issues — such as medical necessity; physician arrangements; research and clinical studies; and False Claims Act, Anti-Kickback Statute, Stark Law, and Eliminating Kickbacks in Recovery Act (EKRA) matters — to emerging challenges involving health equity, delivery of healthcare in rural communities, telehealth and telemedicine, drug diversion strategies, and more. She regularly represents clients in internal and government investigations and proceedings before state and federal regulatory and law enforcement agencies, such as the US Department of Justice; this includes analyzing and preparing numerous self-disclosures under a variety of protocols.

Myla has extensive experience developing, assessing, implementing, and managing compliance programs and has negotiated and implemented numerous corporate integrity agreements. In addition to her work on federal issues, she counsels clients across the country on state regulatory and enforcement matters, including reimbursement, licensure, fraud and abuse, and the impact of innovative and novel state healthcare programs. During the COVID-19 pandemic, Myla offered extensive guidance to providers that were significantly impacted by the public health emergency, including the nursing home and long-term care communities.

A recognized legal and industry thought leader, she has written numerous articles on a broad range of healthcare-related topics, such as recent US Supreme Court rulings and other federal appellate decisions, recent changes to the Anti-Kickback Statute safe harbors, the future of EKRA, advancements in health equity the effectiveness of compliance programs, drug diversion compliance, the landscape of self-disclosures, and responding to COVID-era and post-COVID laws and regulations. Myla helps organize, and regularly speaks at, legal and healthcare industry conferences and has been quoted in numerous articles appearing in publications such as Laboratory Economics, McKnight’s, and Report on Medicare Compliance.  She is active in a statewide organization focused on healthcare compliance and privacy/security trends, where she regulatory speaks on recent enforcement and compliance settlements and trends.

Publications

  • "Recent Trends in Clinical Laboratory Enforcement Action," AHLA Bulletin, July 6, 2023
  • "An Update on the Eliminating Kickbacks in Recovery Act," Law360, March 4, 2023
  • "How Nursing Home Operators Can Stay Atop Shifting Coronavirus Regulations," Health Care Business Today, July 28, 2020
  • "COVID-19 case study: US long-term care facilities," Facility Perspectives, Vol. 14, No. 2, March 17, 2020
  • "Multiple DOJ Settlements Relating to Electronic Health Records Systems—What Does This Mean for Health Care Entities Today?" The RAP Sheet, a publication of the American Health Lawyers Association, May 20, 2019

Presentations

  • "Drug Diversion Overview and Compliance," Health Ethics Trust Webinar, May 1, 2024
  • "The Landscape of Health Equity - What Boards and Compliance Officers Need to Know," Florida Compliance and Privacy Consortium, Gainesville, Florida, April 26, 2024
  • "Federal Agencies Take Action on Health Equity: Preparing for New Provider Requirements and Metrics," American Health Law Association Webinar, April 17, 2024
  • "Drug Diversion Overview and Compliance," Children's Leaders, February 2024
  • "Recent Government Settlements and Enforcements," Florida Compliance and Privacy Consortium, February 2024
  • "Hot Topics in Laboratory Settlement and Regulatory Issues," Health Ethics Trust Webinar, March 2023
  • "What's New in the Lab World—Recent Cases and Enforcement," Louisiana Bar  — Health Law Section, December 1, 2022
  • "LTC Facilities in the COVID Environment," Louisiana Bar — Health Law Section, December 4, 2020
  • "Hot Topics in a COVID-19 Environment," Florida Bar — Health Law Section, October 30, 2020
  • "Long Term Care Facility Infection Control," Stafford Webinar, September 20, 2020
  • "Nursing Homes and Long Term Care Facilities — The New Regulatory and Oversight Landscape in the COVID-19 Environment," ACI LTC Symposium, August 16, 2020
  • "Nursing Homes: The New Frontier in the COVID-19 Environment," Health Ethics Trust Webinar, August 6, 2020
  • "Nursing Homes: The New Frontier in the COVID-19 Environment," Healthcare Council of Western Pennsylvania Webinar, May 28, 2020
  • "Nursing Homes: The New Frontier in the COVID-19 Environment," Health Ethics Trust Webinar, May 18, 2020
  • "Post Acute Care Recent Guidance and Lessons Learned," Healthcare Council of Western Pennsylvania Webinar, April 9, 2020
  • "Stark and Physician Compensation: Hot Topics Do's, Don'ts, and Pitfalls," Orlando, Florida, January 24, 2020
  • "Data Integrity, Certifications and Government Reporting: Where Do We Go From Here?" New Orleans, Louisiana, December 7, 2019
  • "The Melding of Quality & Compliance," Miami, Florida, August 2, 2019
  • "Recent Conflicts of Interest Events," St. Augustine, Florida, June 1, 2019

Memberships

  • Dare to Care; Member, Board of Directors
  • Florida Memorial University; Past Member, Board of Trustees
  • The Florida Bar; Past Member, Health Law Executive Council
Miami
201 S Biscayne Blvd
Citi Center, Suite 3000
Miami, FL 33131-4341
D: 305.679.5743
F: 305.679.5710
Emailmreizen@joneswalker.com

Education

  • University of Pennsylvania
    JD, 1995
  • Vanderbilt University
    BS, 1991

Bar Admissions

  • Florida

Related Practices

  • Corporate
  • Corporate Compliance & White Collar Defense
  • Healthcare

Related Industries

  • Healthcare Industry
Related News & Insights
Type
Press Release
Title
160 Jones Walker Attorneys Recognized in The Best Lawyers in America® 2026
Date
September 2, 2025
Link
Read More
Type
Press Release
Title
Myla Reizen Returns to Jones Walker to Grow Healthcare Industry Team
Date
June 11, 2024
Link
Read More
Type
Firm News
Title
Reizen and Weinstein Present Health Ethics Trust Webinar on Drug Diversion
Date
May 1, 2024
Link
Read More
Type
Firm News
Title
Reizen Presents at Florida Compliance and Privacy Consortium
Date
April 26, 2024
Link
Read More
Type
Firm News
Title
Reizen Presents on American Health Law Association Webinar on Health Equity
Date
April 15, 2024
Link
Read More
Sign Up For Alerts
© 2025 Jones Walker LLP. All Rights Reserved.
PrivacyDisclaimerAvident Advisors
A LexMundi Member

This website uses cookies to deliver a better experience. By continuing on this website, you consent to our use of cookies.